Eledon Pharmaceuticals, Inc.
ELDN • NASDAQ
Eledon Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David-Alexandre C. Gros, with a market cap of $214.7M.
Market Cap$214.7M
Employees20.0
CEODavid-Alexandre C. Gros
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
Eledon Pharmaceuticals, Inc. FAQ
Common questions about Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals, Inc. is scheduled to report earnings for Q1 2026 on May 13, 2026.
Eledon Pharmaceuticals, Inc. has approximately 20 employees.